INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 203 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,647 | -16.5% | 24,800 | +0.4% | 0.00% | – |
| Q2 2023 | $11,550 | +4376.7% | 24,700 | -85.1% | 0.00% | – |
| Q4 2022 | $258 | -99.9% | 165,500 | -2.9% | 0.00% | – |
| Q3 2022 | $286,000 | +8.7% | 170,385 | +16.0% | 0.00% | – |
| Q2 2022 | $263,000 | -55.6% | 146,900 | -9.4% | 0.00% | – |
| Q1 2022 | $592,000 | -61.6% | 162,100 | -45.4% | 0.00% | -100.0% |
| Q4 2021 | $1,541,000 | -43.1% | 296,792 | +3.7% | 0.00% | -50.0% |
| Q2 2021 | $2,707,000 | -5.8% | 286,200 | -12.3% | 0.00% | -20.0% |
| Q1 2021 | $2,875,000 | -34.1% | 326,293 | -32.6% | 0.01% | -28.6% |
| Q4 2020 | $4,360,000 | -64.1% | 484,406 | +26.4% | 0.01% | -78.8% |
| Q2 2020 | $12,141,000 | – | 383,094 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON ASSOCIATES LP | 784,679 | $643,437 | 0.10% |
| Green Alpha Advisors, LLC | 146,300 | $119,966 | 0.08% |
| Virtus ETF Advisers LLC | 54,106 | $44,367 | 0.02% |
| Cedar Brook Financial Partners, LLC | 104,881 | $86,002 | 0.02% |
| PROFUND ADVISORS LLC | 418,749 | $343,374 | 0.02% |
| Arlington Capital Management, Inc. | 27,735 | $22,743 | 0.02% |
| Hennion & Walsh Asset Management, Inc. | 382,158 | $313 | 0.02% |
| Rafferty Asset Management, LLC | 2,647,927 | $2,171,300 | 0.02% |
| Brainard Capital Management LLC | 16,666 | $13,666 | 0.01% |
| Beck Bode, LLC | 41,218 | $33,799 | 0.01% |